These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12875233)

  • 1. [Variance of bioavailability of pharmaceutical preparations and analysis of factors affecting it].
    Mizuno N; Shinkuma D; Hamaguchi T
    Yakugaku Zasshi; 2003 Jul; 123(7):477-93. PubMed ID: 12875233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bioavailability of sulpiride taken as a film-coated tablet with sodium bicarbonate, cimetidine, natural orange juice or hydrochloric acid.
    Shinkuma D; Hamaguchi T; Kobayashi M; Yamanaka Y; Mizuno N
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):499-502. PubMed ID: 2555311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of food intake and meal size on the bioavailability of sulpiride in two dosage forms.
    Shinkuma D; Hamaguchi T; Kobayashi M; Yamanaka Y; Mizuno N
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):440-2. PubMed ID: 2258254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of food intake on the bioavailability of sulpiride from AEA film-coated tablet having a pH-dependent dissolution characteristic in normal or drug-induced achlorhydric subjects.
    Shinkuma D; Hamaguchi T; Kobayashi M; Yamanaka Y; Mizuno N
    Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):303-9. PubMed ID: 1743804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the oral bioavailability of sulpiride by a gastric-retained form in rabbits.
    Kohri N; Naasani I; Iseki K; Miyazaki K
    J Pharm Pharmacol; 1996 Apr; 48(4):371-4. PubMed ID: 8794985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic compartmental model with n sites of absorption along the gastrointestinal tract.
    Plusquellec Y; Houin G
    Arzneimittelforschung; 1994 May; 44(5):679-82. PubMed ID: 8024648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of drugs (first of two parts).
    Koch-Weser J
    N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioavailability of phenytoin: comparison between three preparations.
    Kitzes R; Ackerman Z; Levy M; Frumerman I; Shved A; Garty M
    Isr J Med Sci; 1985 Apr; 21(4):323-6. PubMed ID: 3997494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of mefenamic acid: influence of food and water intake.
    Hamaguchi T; Shinkuma D; Yamanaka Y; Mizuno N
    J Pharm Sci; 1986 Sep; 75(9):891-3. PubMed ID: 3783459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal absorption II. Formulation factors affecting drug bioavailability.
    Blanchard J
    Am J Pharm Sci Support Public Health; 1978; 150(5):132-51. PubMed ID: 364993
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of food on the bioavailability of drugs.
    Melander A
    Clin Pharmacokinet; 1978; 3(5):337-51. PubMed ID: 81118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic drug interactions with phenytoin (Part I).
    Nation RL; Evans AM; Milne RW
    Clin Pharmacokinet; 1990 Jan; 18(1):37-60. PubMed ID: 2178849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel l-sulpiride-loaded quaternary microcapsule: Effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability.
    Kim DS; Kim DW; Kim KS; Choi JS; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Jin SG; Choi HG
    Colloids Surf B Biointerfaces; 2016 Nov; 147():250-257. PubMed ID: 27518457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bioavailability and pharmacokinetics of mefenamic acid in alloxan-diabetic rabbits.
    Qamar S; Irfan N; Ahmad M; Jamshaid M; Muzaffar NA
    Tokai J Exp Clin Med; 1997 Oct; 22(4):163-6. PubMed ID: 9777006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of food on absorption of Dilantin Kapseals and Mylan extended phenytoin sodium capsules.
    Wilder BJ; Leppik I; Hietpas TJ; Cloyd JC; Randinitis EJ; Cook J
    Neurology; 2001 Aug; 57(4):582-9. PubMed ID: 11524464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.
    Fleisher D; Li C; Zhou Y; Pao LH; Karim A
    Clin Pharmacokinet; 1999 Mar; 36(3):233-54. PubMed ID: 10223170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of phenytoin: clinical pharmacokinetic and therapeutic implications.
    Neuvonen PJ
    Clin Pharmacokinet; 1979; 4(2):91-103. PubMed ID: 378503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of doses on the bioavailability of phenytoin from a prompt-release and an extended-release preparation: single dose study.
    Rojanasthien N; Chaichana N; Teekachunhatean S; Kumsorn B; Sangdee C; Chankrachang S
    J Med Assoc Thai; 2007 Sep; 90(9):1883-93. PubMed ID: 17957935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on Ponstan (mefenamic acid): I. Gastro-intestinal blood loss; II. Absorbtion and excretion of a new formulation.
    Tall AR; Mistilis SP
    J Int Med Res; 1975; 3(3):176-82. PubMed ID: 162673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of phenytoin acid and phenytoin sodium with enteral feedings.
    Doak KK; Haas CE; Dunnigan KJ; Reiss RA; Reiser JR; Huntress J; Altavela JL
    Pharmacotherapy; 1998; 18(3):637-45. PubMed ID: 9620116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.